Results 71 to 80 of about 1,128 (134)

Vaccination against pneumococcus in West Africa: perspectives and prospects

open access: yesInternational Journal of General Medicine, 2013
Eric S Donkor,1 Nicholas TKD Dayie,1,2 Ebenezer V Badoe3 1Department of Microbiology, University of Ghana Medical School, Accra, Ghana; 2Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen ...
Donkor ES, Dayie NT, Badoe EV
doaj  

Update on the success of the pneumococcal conjugate vaccine

open access: yesPaediatrics & Child Health, 2011
Several years after the seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in Canada and elsewhere, routine infant vaccination has led to near eradication of invasive pneumococcal disease caused by vaccine serotype strains in both children and adults.
openaire   +2 more sources

Experience with pneumococcal conjugate vaccine in Norway

open access: yesExpert Review of Vaccines, 2009
Seven-valent pneumococcal conjugate vaccine (PCV7) was introduced into the Norwegian childhood vaccination program in July 2006 in a 2+1 dose (three-dose) schedule. Vaccine coverage quickly reached high levels and the incidence rate of invasive pneumococcal disease in children under 2 years of age declined rapidly.
openaire   +2 more sources

Molecular Characterization of Streptococcus pneumoniae Strains Isolated from Patients with Invasive Infections in a Romanian Hospital

open access: yesMicroorganisms
Invasive pneumococcal disease (IPD) results from the dissemination of Streptococcus pneumoniae to normally sterile anatomical sites such as the bloodstream or cerebrospinal fluid. One of the primary roles of pneumococcal conjugate vaccines (PCVs) used in
Endre Csaba Pál   +7 more
doaj   +1 more source

Pneumococcal conjugate vaccine and pneumococcal common protein vaccines

open access: yes, 2013
Keith P. Klugman   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy